Dictionary

allow_url_fopen is ENABLED Dictionary Search

sle

Synonyms

Noun

1. systemic lupus erythematosus

2. SLE, disseminated lupus erythematosus, lupus

Usage
CASE: CAR T-Cell Therapy for Lupus Patient With Kidney Involvement - Cleveland Clinic
Metabolic determinants of autoimmune kidney diseases - Nature
Enpatoran Gets Breakthrough Tx Status for Lupus With Skin Manifestations - Medical Professionals Reference
Study Finds Increased Risk of Kidney Disease in People with Systemic Lupus Erythematosus Without Lupus Nephritis - Lupus Foundation of America
SLE: four trials to watch in 2026 - Clinical Trials Arena
Factors Associated With Fatigue in Systemic Lupus Erythematosus Identified - Docwire News
Enpatoran, a Toll-like receptor 7/8 inhibitor, in moderate-to-severe systemic lupus erythematosus: findings from Cohort B of a multicentre, international, double-blind, placebo-controlled dose-finding phase 2 trial - The Lancet
SLE program offers glimpse of West Point’s immense possibilities for prospective high school students - United States Military Academy West Point
Immune-Mediated Demyelinating Polyradiculoneuropathies Linked to Systemic Lupus Erythematosus (SLE): A Systematic Review of Clinical Features, Diagnostic and Treatment Modalities - Cureus
Positioning rituximab in the therapeutic strategies for SLE - Frontiers
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus - Biogen
Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial - Nature
Update: Gazyva® significantly reduces disease activity in adults with systemic lupus erythematosus - Lupus Foundation of America
Alterations in peripheral blood B cell subsets and their clinical significance in systemic lupus erythematosus - Nature
Phase III Study Shows Positive Results for Gazyva® in Systemic Lupus Erythematosus - Lupus Foundation of America
Prasugrel inhibits TLR7-driven autoimmunity in systemic lupus erythematosus by acetylating cGAS - Nature
FDA Accepts Supplemental Biologics Application for Gazyva® in Systemic Lupus Erythematosus - Lupus Foundation of America
Mechanistic link uncovered between EBV infection and SLE - Nature
Single-cell profiling unveils nephritis-related circulating immunological signatures in systemic lupus erythematosus patients - Nature
Efficacy of mebendazole in the spontaneous NZBxNZWF1 animal model of systemic lupus erythematosus - Nature
Late-Onset Systemic Lupus Erythematosus: Is It Really a Benign Disease? - Cureus
Complement and autoantibody levels under anifrolumab therapy in SLE: implications for clinical practice - Frontiers
Nipocalimab Shows 58% Response Rate in Autoantibody-Positive SLE Patients - The Clinical Trial Vanguard
EBV and SLE: causal or concurrence? - The Lancet
Study finds Anifrolumab may help restore overall immune health in people with systemic lupus erythematosus - Lupus Foundation of America
Loss-of-function mutations in PLD4 lead to systemic lupus erythematosus - Nature
A Phase 3 Trial of Telitacicept for Systemic Lupus Erythematosus - The New England Journal of Medicine
New Study Finds Potential Biomarker Linking Fat Imbalance to Systemic Lupus Erythematosus - Lupus Foundation of America
Effects of telitacicept and belimumab on systemic lupus erythematosus: a systematic review and meta-analysis - Nature
Johnson & Johnson reports phase 2 data showing nipocalimab reduced SLE disease activity - PharmaTimes
Acute Pericarditis: An Isolated Initial Manifestation of Systemic Lupus Erythematosus (SLE) - Cureus
Nipocalimab Reduces Disease Activity in Moderate-to-Severe SLE in Phase 2 Trial - HCPLive
SLE and LN market expected to reach $5.9bn across 7MM by 2034 - Pharmaceutical Technology
Nipocalimab Delivers Positive Phase IIb Results in JASMINE SLE Trial - Applied Clinical Trials Online
American College of Rheumatology Releases 2025 Treatment Guideline for SLE - Dermatology Advisor
SLE program offers glimpse of West Point’s immense possibilities for prospective high school students - DVIDS
Anti-CD38 monoclonal antibody CM313 for systemic lupus erythematosus: a randomized, double-blind, placebo-controlled phase Ib/IIa trial - Nature
Study reveals link between cytomegalovirus infection and systemic lupus erythematosus - Lupus Foundation of America
UPDATE: FDA Grants Fast Track Designation to Johnson & Johnson’s Investigational Therapy, Nipocalimab, for Adults with Systemic Lupus Erythematosus - Lupus Foundation of America
Using objective measures of physical activity, sleep, and breathing for disease profiling of patients with systemic lupus erythematosus and Sjögren's disease - Frontiers
A Case of Systemic Lupus Erythematosus Initially Presenting With Generalized Lymphadenopathy: A Diagnostic Challenge - Cureus
Saphnelo SC Approval Expands Delivery Options for SLE Patients - Clinical Advisor
Organizing Pneumonia As the Initial Manifestation of Systemic Lupus Erythematosus: Case Report and Literature Review - Cureus
Randomized Trial Supports Sirolimus as Add-On Systemic Lupus Erythematosus Therapy - Medscape
Belimumab Monotherapy Matches Combination Therapy in Systemic Lupus Erythematosus - Medscape
Cost-utility analysis of telitacicept versus belimumab in the treatment of systemic lupus erythematosus in China - Frontiers
FDA Accepts BLA for Gazyva/Gazyvaro for Systemic Lupus Erythematosus - BioPharm International
Two Cases of Systemic Lupus Erythematosus With Castleman Disease - Cureus
Clinical and Immunological Profiles With Treatment Patterns in Systemic Lupus Erythematosus Patients in the Eastern Part of India: A Retrospective, Hospital-Based, Cross-Sectional Study - Cureus
“I refuse to let lupus get me down”: A lupus patient's story - Johnson & Johnson
Biogen to Present Additional Results from Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus at ACR Convergence 2025 - Biogen
How The Investment Story For Super League Enterprise (SLE) Is Shifting After Analyst Reset - Yahoo Finance
Aberrant B cell responses as drivers of autoantibody generation and epitope diversification in SLE pathogenesis - Frontiers
Insights into the pathogenesis of childhood-onset SLE in the past decade - Nature
New study identifies 15 herbal supplements to potential skin flare activity in people with autoimmune skin diseases - Lupus Foundation of America
New study finds link between Epstein-Barr virus and the development of Systemic Lupus Erythematosus - Lupus Foundation of America
Systemic Lupus Erythematosus: Emerging Insights into Diagnosis, Treatment, and Prognosis - Science Partner Journals
Case Report: Telitacicept in the treatment of systemic lupus erythematosus complicated by acquired hemophilia A - Frontiers
The microbiota-systemic lupus erythematosus axis: mechanisms, diagnostics, and therapeutic frontiers - Frontiers
Obinutuzumab Under Review for Systemic Lupus Erythematosus - Medical Professionals Reference
FDA Approves First-in-Class Weekly Anifrolumab Autoinjector for Systemic Lupus Erythematosus - AJMC
Successful Treatment of Pure Red Cell Aplasia in Systemic Lupus Erythematosus With a Combination of Rituximab and Mycophenolate Mofetil - Cureus
Silent Storm: Advanced Heart Failure in a Young Female Patient With Systemic Lupus Erythematosus - Cureus
Update: Dapirolizumab pegol plus standard of care improves disease activity in systemic lupus erythematosus - Lupus Foundation of America
FDA Approves SAPHNELO Self-Administration for Treatment of Systemic Lupus Erythematosus - Lupus Foundation of America
American College of Rheumatology Releases New SLE Guidelines - Lupus Foundation of America
Systemic Lupus Erythematosus (SLE) Complicated by Human Immunodeficiency Virus (HIV): A Rare and Challenging Association - Cureus
Early Steroid Pulses Tied to Lower Damage/Death Risk in SLE - Medscape
BLyS-Specific Inhibition for Active Systemic Lupus Erythematosus and Lupus Nephritis to Improve Patient Outcomes - Rheumatology Advisor
New 52-Week Data Reinforce Deucravacitinib’s Benefits for Psoriatic Arthritis and SLE - Dermatology Times
Thoracic Imaging Findings in Systemic Lupus Erythematosus - Cureus
Azathioprine Exposure Associated with Liver Condition in Systemic Lupus Erythematosus Pregnancies - Lupus Foundation of America
Disease activity maintenance and prevalence in people with systemic lupus erythematosus with clinically active disease - Lupus Foundation of America
TLR7/8 Inhibitor Reduces Cutaneous Disease Activity in SLE - European Medical Journal
J&J’s nipocalimab posts win in Phase II SLE trial - Clinical Trials Arena
Systemic Lupus Erythematosus-Associated Myelitis Mimicking Spinal Glioblastoma: A Case Report - Cureus
Applications of artificial intelligence in systemic lupus erythematosus: integrating multi-omics data for precision medicine - Frontiers
Sixth Street Raises €3.75 Billion for Third European Direct Lending Fund - Sixth Street
Biogen Highlights Multiple Assets and Indications in Lupus - Biogen
Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial - Nature
CAR-T Cell Therapy Induces Durable Remission in SLE - European Medical Journal
New study confirms significant association between Epstein-Barr Virus infection and systemic lupus erythematosus - Lupus Foundation of America
Case Report: Relapsing systemic lupus erythematosus treated with dual rituximab and anifrolumab therapy - Frontiers
Stifel reiterates Alumis stock Buy rating ahead of lupus data By Investing.com - Investing.com Canada
New research links discrimination to worse Systemic Lupus Erythematosus-related symptoms and mental health outcomes - Lupus Foundation of America
FDA Approves Anifrolumab-fnia Autoinjector for SLE Self-Administration, Offering Subcutaneous Option - Pharmacy Times – Pharmacy Practice News and Expert Insights
Phase IIb Study Results of InnoCare’s Orelabrutinib in Patients with SLE Presented at 2026 EULAR - Yahoo Finance
ACR 2025: Implementing SLE and LN Guidelines Into Practice - Medscape
Neuropsychiatric Systemic Lupus Erythematosus Diagnosed Following Treatment Initiated for Acute Encephalitis - Cureus
Overlap of Toxic Epidermal Necrolysis (TEN)-Like Cutaneous Lupus and Rowell Syndrome in Systemic Lupus Erythematosus: A Case-Based Review - Cureus
Age-stratified risk factors and predictive models for progression to lupus nephritis in patients with systemic lupus erythematosus: a review - Frontiers
Blood Test Reveals Risks in Antiphospholipid Syndrome, SLE - Medscape
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial - Nature
Advances in understanding the Th17/Treg balance in systemic lupus erythematosus: implications for treatment and management - Frontiers
Efficacy and safety of allogeneic CD19 CAR NK-cell therapy in systemic lupus erythematosus: a case series in China - The Lancet
Acute Psychosis as the Sole Initial Manifestation of Systemic Lupus Erythematosus: A Diagnostic Challenge - Cureus
The Anti-Lupus Plate: Mapping Nutritional Interventions to Inflammatory Pathways in Systemic Lupus Erythematosus - Wiley Online Library
Journal of Hepato-Biliary-Pancreatic Sciences | JSHBPS Pancreas Journal - Wiley Online Library
Bullous Systemic Lupus Erythematosus as a Marker of Treatment-Refractory Systemic Disease: A Case Report - Cureus
EMD Serono Announces FDA Breakthrough Therapy Designation for Enpatoran in Lupus Patients with Active Skin Manifestations - Business Wire
Foreign Language Equivalents
Foreign Language Equivalents of 'sle'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
slee,   se,   slw,   ske,   slle,   slr,   dle,   sel,   ale,   s;e,   ssle,   lse,   sl,   le
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z